Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by hopskipjumpon May 18, 2005 12:24am
331 Views
Post# 9048638

RE: Pool

RE: PoolI sort of think this could be a $20 stock if they can get the science moving further along.... -------but----------- but the nagging pain in my neck keeps telling me this story: control is sold for $7.50 to $8.00 range then massive mysterious short position appears management retires and get sweet options on the next ride NR's dry up Maximum options each year at lower and lower prices cash burn is wild new money is desperately needed anti dilution clauses allow a few to rest easy years go by shareholders get tired and sell (tax loss is their upside) trading is flat flat flat more control is bought company gets sold in PhaseIII to same company for a song (if it proves out) and short is covered for a tidy sum otherwise the massive short position makes holders big dough the technology and research is shelved for a year or so and then gets a new spin and we start again -------OR--------- we each get $68 US cash, plus new shares, options to reinvest at the old price, free airplane rides and life time passes to the waterpark but lets face it, I don't have a clue, who does??? anyway, know your personal sell price, and have some FUN! good tradin' -oldtimer p.s. I think we may see another retrace in the next 2 or 3 sessions
Bullboard Posts